Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-17

Clinical Trial Update: Treatment of Gingival Recession Using Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating mesenchymal stem cells for treating gingival recession has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Gingival Recession | Phase 1, Phase 2 | Status: COMPLETED